Further, to confirm whether FOXD1‐AS1 modulated FOXD1 in GC via the PI3K/AKT/mTOR pathway, PI3K activator (740Y‐P) was used to conduct rescue assays in FOXD1‐AS1‐inhibited GC cells. Here, FOXD1 is linked to gastric cancer.